65,437 trials
Diabetes Mellitus
Primary: Number of Results From the Contour Next BGMSs Reference Values Within ±12.5% of Reference Values — 240 blood samples
Spina Bifida · Myelomeningocele · Neural Tube Defects
Primary: Maternal Adverse Events — 2 participants
Severe Asthma
Primary: Airway Resistance at 5 Hz (R5) at Baseline (Pre-mepolizumab Initiation) — 0.51; 0.39; 0.43 kPa/L/s
Healthy
Primary: Area Under the Concentration-time Curve of Bupropion in Plasma Over the Time Interval From 0 to the Last Quantifiable Data Point (AUC0-tz) — 2953; 2795 hours *…
Spinal Cord Injuries · Pneumonia
Primary: Pneumonia — 70 Participants
Knee Osteoarthritis
Primary: Western Ontario and McMaster University's Osteoarthritis Index (WOMAC) — 24.9; 22.4; 26.1; 22.3 score on a scale
Advanced Solid Tumor
Primary: Broad Panel and Pediatric Cohorts: Objective Response Rate (ORR) Based on Response Assessment in Neuro-Oncology (RANO) as Assessed by Independent Review Committee (IRC)…
Conjunctivitis, Allergic
Primary: Subject-Reported Ocular Itching Score — 16.410; 16.964; 22.310 units on a scale
Surgery
Primary: Phase 2- Cumulative Duration of Vital Sign Abnormalities — 6.2; 4.2; 0; 0 minutes beyond threshold — p=< 0.05
Adolescent Behavior · Social Stress
Primary: Cortisol AUCi — 0.0043; 0.0256; 0.0177; 0.022 (ug/dl)*minutes
Chronic Insomnia
Primary: Change in Insomnia Symptom Severity — -8.05; -7.82; -10.19 change score on a scale
Neovascular Age-related Macular Degeneration
Primary: Number of Patients Classified as q12w Fluid-free or Not q12w Fluid-free — 93; 27 Participants
Respiratory Syncytial Virus Infection
Primary: Maximum Observed Plasma Concentration (Cmax) of Sisunatovir on Day 1 — 80.14 nanogram per milliliter (ng/mL)
Aphasia · Stroke
Primary: Change in the Depression Score on Hospital Anxiety and Depression Scale at Post-Intervention — 2.2 units on a scale — p=< .05
Autism Spectrum Disorder
Primary: Safety of hCT-MSC Infusion as Measured by Total Number of Infusion Reactions — 1 infusion reactions